Literature DB >> 24284605

The diagnostic value of vestibular evoked myogenic potentials in patients with Meniere's disease.

Naoya Egami1, Munetaka Ushio, Tatsuya Yamasoba, Takuhiro Yamaguchi, Toshihisa Murofushi, Shinichi Iwasaki.   

Abstract

OBJECTIVE: To estimate the sensitivity and specificity of vestibular evoked myogenic potentials (VEMPs) in comparison with caloric test in diagnosing Meniere's disease (MD) among patients with dizziness.
METHODS: Data were retrospectively collected from 1,170 consecutive patients who underwent vestibular tests. Among them, 114 patients were diagnosed as having unilateral definite MD. VEMPs in response to clicks and short tone burst stimulation as well as caloric tests were performed. The sensitivity and specificity of each test were evaluated. The results of each test were compared with hearing level and staging of MD.
RESULTS: The sensitivity and specificity of VEMPs were 50.0% and 48.9%, while those of the caloric test were 37.7% and 51.2%, respectively. There was no significant difference in hearing level between patients appropriately or inappropriately identified by VEMPs, whereas there was a significant difference in those of the caloric test. Combined use of VEMP and caloric test increased the sensitivity to 65.8%.
CONCLUSION: Although the sensitivity and specificity of VEMPs in diagnosing MD were not high, they were comparable to those of caloric test. VEMPs as well as caloric testing may give additional information as part of a diagnostic test battery for detecting vestibular abnormalities in MD.

Entities:  

Keywords:  Meniere's disease; caloric test; endolymphatic hydrops; staging; vestibular evoked myogenic potentials

Mesh:

Year:  2013        PMID: 24284605     DOI: 10.3233/VES-130484

Source DB:  PubMed          Journal:  J Vestib Res        ISSN: 0957-4271            Impact factor:   2.435


  8 in total

1.  Cervical Vestibular Evoked Myogenic Potentials in Menière's Disease: A Comparison of Response Metrics.

Authors:  Kimberley S Noij; Barbara S Herrmann; John J Guinan; Steven D Rauch
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

2.  Role of Cervical Vestibular Evoked Myogenic Potentials (cVEMP) as Outcome-Measure of Glycerol Test.

Authors:  Deepa A Valame; Geeta B Gore
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-05-27

3.  Clinical characteristics in unilateral vestibular atelectasis.

Authors:  Morgane Marc; Charlotte Hautefort; Jean-Pierre Guichard; Philippe Herman; Emmanuel Houdart; Michel Toupet; Michael Eliezer
Journal:  J Neurol       Date:  2020-09-09       Impact factor: 4.849

4.  Evaluation of the otolith function using c/oVEMPs in patients with Ménière's disease.

Authors:  Liang Chen; Hui Xu; Wu-Qing Wang; Qing-Quan Zhang; Qiao-Ying Lv; Xi-Cheng Song
Journal:  J Otolaryngol Head Neck Surg       Date:  2016-06-21

5.  Clinical application of cVEMPs and oVEMPs in patients affected by Ménière's disease, vestibular neuritis and benign paroxysmal positional vertigo: a systematic review.

Authors:  A Scarpa; F M Gioacchini; E Cassandro; M Tulli; M Ralli; M Re; C Cassandro
Journal:  Acta Otorhinolaryngol Ital       Date:  2019-10       Impact factor: 2.124

6.  Vestibular Endolymphatic Hydrops Visualized by Magnetic Resonance Imaging and Its Correlation With Vestibular Functional Test in Patients With Unilateral Meniere's Disease.

Authors:  Yupeng Liu; Fan Zhang; Baihui He; Jingchun He; Qing Zhang; Jun Yang; Maoli Duan
Journal:  Front Surg       Date:  2021-06-04

Review 7.  Diagnostic Value of Vestibular Evoked Myogenic Potentials in Endolymphatic Hydrops: A Meta-Analysis.

Authors:  Sulin Zhang; Yangming Leng; Bo Liu; Hao Shi; Meixia Lu; Weijia Kong
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

8.  Evaluation of vestibular evoked myogenic potentials (VEMP) and electrocochleography for the diagnosis of Ménière's disease.

Authors:  Pauliana Lamounier; Thiago Silva Almeida de Souza; Debora Aparecida Gobbo; Fayez Bahmad
Journal:  Braz J Otorhinolaryngol       Date:  2016-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.